Blockchain Registration Transaction Record

Sigyn Therapeutics Appoints Apheresis Expert to Advance Cardiovascular Treatment

Sigyn Therapeutics appoints Dr. Christoph Zaba to advance Sigyn Therapy™, a breakthrough treatment for cardiovascular disease using existing dialysis machines to expand access to life-saving care.

This development matters because cardiovascular disease remains the leading cause of death globally, affecting millions of people worldwide. The expansion of accessible treatment options through technologies like Sigyn Therapy™ could revolutionize cardiovascular care by making life-saving apheresis treatments available in thousands of dialysis clinics rather than just a few dozen specialized centers. For patients with high lipoprotein levels and cardiovascular risk, this technology could significantly reduce the incidence of heart attacks, strokes, and other major adverse events. The involvement of an experienced medical technology leader like Dr. Zaba accelerates the potential commercialization of this innovative therapy, which could ultimately save lives and reduce healthcare costs associated with cardiovascular complications.